Collagen Peptides for Skin Aging

Verdict: Promising but not yet proven

Oral collagen peptides show preliminary evidence for modestly improving skin elasticity, hydration, and wrinkles, but the supporting trials are largely industry-funded and major regulators have not endorsed the claims.

B 🟡 B Preliminary Evidence Published

🔬Why this grade7-layer evidence engine

Two meta-analyses point the same direction. Choi 2019 (PMID 30681787), pooling 11 RCTs (n=805), found significant gains in skin elasticity (SMD 0.72) and hydration (SMD 0.31) with modest wrinkle improvement versus placebo. Pu 2023 (PMID 37432180), covering 26 RCTs (n=1,721), confirmed the hydration and elasticity benefits, and the representative Verisol RCT (PMID 24401291, n=114) showed reduced eye-wrinkle volume after 8 weeks at 2.5 g/day. This consistent positive signal is what lifts the grade to preliminary evidence.

The grade stays at B rather than higher because the evidence base has serious limitations. Nearly all underlying trials were funded by collagen manufacturers (Gelita/Verisol, Rousselot), Pu 2023's funnel plot suggested publication bias inflating the pooled effect, and heterogeneity across sources, doses (2.5-10 g/day), and durations was moderate-to-high. Most participants were middle-aged women, limiting generalizability.

Regulators have not backed these claims. The EU EFSA concluded 'a cause and effect relationship has not been established between the consumption of collagen hydrolysate and maintenance of joints,' and separately rejected the Verisol skin-elasticity claim. The US FDA lists collagen only as a food ingredient (flavoring/flavor enhancer), not an efficacy endorsement, and the UK NHS offers no guidance and excludes it from its vitamins and minerals list. The mismatch between a large reported effect and cautious independent regulators is why this is graded as promising but unproven.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.63
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
B · Published
Confidence
70%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L1 ExamineGlobal benchmark
0.50
L5 Clinical bodiesAuthoritative stance
0.55
L3 MechanismPlausibility
0.65
L11 AI re-checkIndependent read
0.65
L2 PubMedPrimary literature
0.70
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.625
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (3)L2 · primary research & systematic reviews

Oral Collagen Supplementation: A Systematic Review of Dermatological Applications
PMID: 30681787 2019 統合分析 n = 805
Finding: Pooled analysis of 11 RCTs (n=805) found statistically significant improvements in skin elasticity (SMD 0.72) and hydration (SMD 0.31), with modest reductions in wrinkle depth, versus placebo. Authors note favorable short-term efficacy and good safety profile but call for longer-term independent trials.
🟢 High quality Mixed funding Effect size: Elasticity SMD 0.72; Hydration SMD 0.31; Wrinkles modest improvement
View on PubMed
Effects of Oral Collagen for Skin Anti-Aging: A Systematic Review and Meta-Analysis
PMID: 37432180 2023 統合分析 n = 1,721
Finding: Updated meta-analysis of 26 RCTs (n=1,721) confirmed Choi 2019 direction: significant improvements in skin hydration and elasticity vs placebo. Subgroup analyses suggested benefit persisted across products and durations >=8 weeks. Heterogeneity moderate-to-high; funnel plots indicated possible publication bias.
🟢 High quality Mixed funding Effect size: Significant pooled benefits on hydration and elasticity (effect magnitudes consistent with Choi 2019)
View on PubMed
Oral Supplementation of Specific Collagen Peptides Has Beneficial Effects on Human Skin Physiology: A Double-Blind, Placebo-Controlled Study
PMID: 24401291 2014 RCT (double-blind) n = 114
Finding: In women aged 45-65, 8 weeks of Verisol 2.5 g/day produced statistically significant reduction in eye wrinkle volume vs placebo (effect persisted 4 weeks post-treatment). Skin biopsy showed increased pro-collagen type I (+65%) and elastin (+18%).
⚠️ Industry-funded Effect size: Eye wrinkle volume reduction statistically significant vs placebo at 4 and 8 weeks
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
COLLAGEN — CAS Reg. No. 9007-34-5; Other Names: COLLAGENS, ATELOCOLLAGEN; Permitted Technical Effects: FLAVOR ENHANCER, FLAVORING AGENT OR ADJUVANT, SOLVENT OR VEHICLE. source↗
L4b EU EFSA
Against
a cause and effect relationship has not been established between the consumption of collagen hydrolysate and maintenance of joints source↗
L4d TW TFDA / 衛福部
Cautious
膠原蛋白為人體本身就可自行合成之物質……(口服)經過消化作用,變成小分子的胺基酸,未必能在體內重新合成膠原蛋白;(塗抹式)僅可能達到表面保濕、潤澤肌膚的效果,無法吸收再利用。 source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬3 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-skin-aging-INT-collagen-peptides-001 繁體中文版 →